Acetylcholine (ACh) is predominantly decomposed by AChE compared to BuChE, thus the inhibition of AChE to increase the level of ACh remains a promising strategy for the treatment of Alzheimer’s disease [9,10]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.